Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

148 new drugs to be eligible for insurance reimbursement in China

  • 1.  148 new drugs to be eligible for insurance reimbursement in China

    Posted 15-Oct-2019 16:22
    Hope everyone had a nice weekend! 

    I wanted to share with our RAPS community information on 148 new drugs that will soon be eligible for insurance reimbursement in China. 

    Moving to make it easier for innovative drug therapies to enter the Chinese market, the country's National Healthcare Security Administration (NHSA) announced in August 2019 it will make 148 new drugs eligible for insurance reimbursement. Altogether, patients will be able to seek varying levels of reimbursement for more than 2,800 drugs and therapies. The drugs covered include more than 1,200 chemical and biological drugs and therapies produced by Western companies, more than 1,000 drugs patented by Chinese firms and more than 800 traditional Chinese medicines. But NGSA authorities removed about as many drugs from the list – 150 – as they added. Among the products removed were some deemed to have low clinical value and others that were replaced with improved therapies.

    ------------------------------
    Ames Gross
    President
    Pacific Bridge Medical
    Bethesda, MD
    www.pacificbridgemedical.com
    contact@pacificbridgemedical.com
    ------------------------------


Related Content